The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
An Evidence-based Staging System for Cutaneous Melanoma
Open accessAbstract
A completely revised staging system for cutaneous melanoma was implemented in 2003. The changes were validated with a prognostic factors analysis involving 17,600 melanoma patients from prospective databases. This major collaborative study of predicting melanoma outcome was conducted specifically for this project, and the results were used to finalize the criteria for this evidence-based staging system. In fact, this was the largest prognostic factors analysis of prospectively followed melanoma patients ever conducted. Important results that shaped the staging criteria involved both the tumor-node-metastasis (TNM) criteria and stage grouping for all four stages of melanoma. Major changes in the staging include: (1) melanoma thickness and ulceration are the dominant predictors of survival in patients with localized melanoma (Stages I and II); deeper level of invasion (ie, IV and V) was independently associated with reduced survival only in patients with thin or T1 melanomas. (2) The number of metastatic lymph nodes and the tumor burden were the most dominant predictors of survival in patients with Stage III melanoma; patients with metastatic nodes detected by palpation had a shorter survival compared with patients whose nodal metastases were first detected by sentinel node excision of clinically occult or "microscopic" metastases. (3) The site of distant metastases (nonvisceral versus lung versus all other visceral metastatic sites) and the presence of elevated serum lactate dehydrogenase (LDH) were the dominant predictors of outcome in patients with Stage IV or distant metastases. (4) An upstaging was implemented for all patients with Stage I, II, and III disease when a primary melanoma is ulcerated by histopathological criteria. (5) Satellite metastases around a primary melanoma and in-transit metastases were merged into a single staging entity that is grouped into Stage III disease. (6) A new convention was implemented for defining clinical and pathological staging so as to take into account the new staging information gained from lymphatic mapping and sentinel node biopsy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Technical Details of Intraoperative Lymphatic Mapping for Early Stage Melanoma
Morton, D. L. (1992) · Archives of Surgery · doi:10.1001/archsurg.1992.01420040034005 · Cited by 4,371
Self-citationFinal Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma
Balch, C. M., Buzaid, A. C., Soong, S.-J., Atkins, M. B., Cascinelli, N., Coit, D. G., Fleming, I. D., Gershenwald, J. E., Houghton, A., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3635 · Cited by 2,636
Self-citationThickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous Melanoma
Breslow, A. (1970) · Annals of Surgery · doi:10.1097/00000658-197011000-00017 · Cited by 2,426
Balch, C. M., Soong, S.-J., Gershenwald, J. E., Thompson, J. F., Reintgen, D. S., Cascinelli, N., Urist, M., McMasters, K. M., Ross, M. I., Kirkwood, J. M., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.16.3622 · Cited by 2,388
Self-citationThe histogenesis and biologic behavior of primary human malignant melanomas of the skin.
Clark, W. H., From, L., Bernardino, E. A., & Mihm, M. C. (1969) · PubMed · Cited by 2,112
Self-citationBALCH, C. M., MURAD, T. M., SOONG, S.-J., INGALLS, A. L., HALPERN, N. B., & MADDOX, W. A. (1978) · Annals of Surgery · doi:10.1097/00000658-197812000-00004 · Cited by 576
Self-citationPrognostic factors in 1,521 melanoma patients with distant metastases.
Barth, A., Wanek, L. A., & Morton, D. L. (1995) · PubMed · Cited by 569
Self-citationThe prognostic significance of ulceration of cutaneous melanoma
Balch, C. M., Wilkerson, J. A., Murad, T. M., Soong, S.-J., Ingalls, A. L., & Maddox, W. A. (1980) · Cancer · doi:10.1002/1097-0142(19800615)45:12<3012::aid-cncr2820451223>3.0.co;2-o · Cited by 361
Self-citationDeichmann, M., Benner, A., Bock, M., Jäckel, A., Uhl, K., Waldmann, V., & Näher, H. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.6.1891 · Cited by 231
Prognostic factors for survival of patients treated systemically for disseminated melanoma.
Eton, O., Legha, S. S., Moon, T. E., Buzaid, A. C., Papadopoulos, N. E., Plager, C., Burgess, A. M., Bedikian, A. Y., Ring, S., Dong, Q., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.3.1103 · Cited by 218
Self-citation
Cited by
Mocellin, S., Pasquali, S., Rossi, C. R., & Nitti, D. (2010) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djq009 · Cited by 527
Cummins, D. L., Cummins, J. M., Pantle, H., Silverman, M. A., Leonard, A. L., & Chanmugam, A. (2006) · Mayo Clinic Proceedings · doi:10.4065/81.4.500 · Cited by 367
Petrelli, F., Cabiddu, M., Coinu, A., Borgonovo, K., Ghilardi, M., Lonati, V., & Barni, S. (2015) · Acta Oncologica · doi:10.3109/0284186x.2015.1043026 · Cited by 323
Update on Bispectral Index monitoring
Johansen, J. W. (2006) · Best Practice & Research Clinical Anaesthesiology · doi:10.1016/j.bpa.2005.08.004 · Cited by 313
Jensen, T. O., Schmidt, H., Møller, H. J., Høyer, M., Maniecki, M. B., Sjoegren, P., Christensen, I. J., & Steiniche, T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.9919 · Cited by 299
Metadata
- Authors
- Balch, C. M., Soong, S.-J., Atkins, M. B., Buzaid, A. C., Cascinelli, N., Coit, D. G., Fleming, I. D., Gershenwald, J. E., Houghton, A., Kirkwood, J. M., McMasters, K. M., Mihm, M. F., Morton, D. L., Reintgen, D. S., Ross, M. I., Sober, A., Thompson, J. A., & Thompson, J. F.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2004-05-01
- Volume
- 54
- Issue
- 3
- Pages
- 131-149
- ISSN
- 0007-9235 (ISSN-L)
- OpenAlex
- W2136421130
- Cited by
- 391
- References
- 14
- FWCI
- 12.78
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An Evidence-based Staging System for Cutaneous Melanoma. https://app.cochat.ai/papers/10.3322/canjclin.54.3.131
- The paper
- Balch, C. M., Soong, S.-J., Atkins, M. B., Buzaid, A. C., Cascinelli, N., Coit, D. G., Fleming, I. D., Gershenwald, J. E., Houghton, A., Kirkwood, J. M., McMasters, K. M., Mihm, M. F., Morton, D. L., Reintgen, D. S., Ross, M. I., Sober, A., Thompson, J. A., & Thompson, J. F. (2004). An Evidence-based Staging System for Cutaneous Melanoma. CA: A Cancer Journal for Clinicians. https://doi.org/10.3322/canjclin.54.3.131
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.